An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer

JOURNAL ARTICLE published April 2016 in Investigational New Drugs

Authors: Andrea Necchi | Salvatore Lo Vullo | Luigi Mariani | Daniele Raggi | Patrizia Giannatempo | Giuseppina Calareso | Elena Togliardi | Flavio Crippa | Nicola Di Genova | Federica Perrone | Maurizio Colecchia | Biagio Paolini | Giuseppe Pelosi | Nicola Nicolai | Giuseppe Procopio | Roberto Salvioni | Filippo G. De Braud